Skip to content

Dehydration of Omafilcon A Contact Lenses Versus Delefilcon A Contact Lenses

Dehydration of Omafilcon A Contact Lenses Versus Delefilcon A Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02366910
Enrollment
26
Registered
2015-02-19
Start date
2015-03-31
Completion date
2015-04-30
Last updated
2020-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The study will explore in vivo lens dehydration rates across a 12hr wear period for the study lenses.

Detailed description

The study will explore in vivo lens dehydration rates across a 12hr wear period for the study lenses. The primary outcome variable for this study is the loss in lens weight over the day, which will indicate the amount of dehydration that has occured.

Interventions

Each subject randomized to wear either the test or control in either the left of right eye.

Each subject randomized to wear either the test or control in either the left of right eye.

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Is at least 17 years of age and has full legal capacity to volunteer; 2. Has read and signed an information consent letter; 3. Is willing and able to follow instructions and maintain the appointment schedule; 4. Is a current wearer of soft contact lenses and has worn them (any brand) more than 3 months. 5. Is able to wear lenses for at least 12 hours a day.

Exclusion criteria

1. Is participating in any concurrent clinical study; 2. Has any known active\* ocular disease and/or infection; 3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable; 4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable; 5. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study; 6. Has undergone refractive error surgery; * \*For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.

Design outcomes

Primary

MeasureTime frameDescription
Absolute Change in Water Content (Mean) of Omafilcon A and Delefilcon A12 Hours of WearComparison between lens types up to and at 12 hours of wear for the absolute change in water content (WC).
Absolute Change in Water Content (Median) of Omafilcon A and Delefilcon A12 Hours of WearComparison between lens types up to and at 12 hours of wear for the absolute change in water content (WC).
Moisture Retention (Mean) of Omafilcon A and Delefilcon A12 HoursComparison between lens types up to and at 12 hours of wear of moisture retention by measuring relative percentage dehydration (RPD).
Moisture Retention (Median) of Omafilcon A and Delefilcon A12 HoursComparison between lens types up to and at 12 hours of wear of moisture retention by measuring relative percentage dehydration (RPD).

Countries

Canada

Participant flow

Participants by arm

ArmCount
Overall Participants
Each subject will be randomized to wear the test lens in one eye and control lens in the other eye (contra lateral design). omafilcon A: Each subject randomized to wear either the test or control in either the left of right eye. delefilcon A: Each subject randomized to wear either the test or control in either the left of right eye.
21
Total21

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyScreen Failure3
Overall StudyWithdrawal by Subject2

Baseline characteristics

CharacteristicOverall Participants
Age, Continuous24 years
Sex: Female, Male
Female
16 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 260 / 26
serious
Total, serious adverse events
0 / 260 / 26

Outcome results

Primary

Absolute Change in Water Content (Mean) of Omafilcon A and Delefilcon A

Comparison between lens types up to and at 12 hours of wear for the absolute change in water content (WC).

Time frame: 12 Hours of Wear

Population: Because of the outliers across three participants, the sample size for statistical analysis is reduced to 18 pairs.

ArmMeasureValue (MEAN)Dispersion
Omafilcon AAbsolute Change in Water Content (Mean) of Omafilcon A and Delefilcon A1.59 absolute WC changeStandard Deviation 0.85
Delefilcon AAbsolute Change in Water Content (Mean) of Omafilcon A and Delefilcon A3.82 absolute WC changeStandard Deviation 1.75
Primary

Absolute Change in Water Content (Median) of Omafilcon A and Delefilcon A

Comparison between lens types up to and at 12 hours of wear for the absolute change in water content (WC).

Time frame: 12 Hours of Wear

Population: Because of the outliers across three participants, the sample size for statistical analysis is reduced to 18 pairs.

ArmMeasureValue (MEDIAN)
Omafilcon AAbsolute Change in Water Content (Median) of Omafilcon A and Delefilcon A1.20 absolute WC change
Delefilcon AAbsolute Change in Water Content (Median) of Omafilcon A and Delefilcon A3.38 absolute WC change
Primary

Moisture Retention (Mean) of Omafilcon A and Delefilcon A

Comparison between lens types up to and at 12 hours of wear of moisture retention by measuring relative percentage dehydration (RPD).

Time frame: 12 Hours

Population: Because of the outliers across three participants, the sample size for statistical analysis is reduced to 18 pairs.

ArmMeasureValue (MEAN)Dispersion
Omafilcon AMoisture Retention (Mean) of Omafilcon A and Delefilcon A2.58 percentage of dehyrdationStandard Deviation 1.38
Delefilcon AMoisture Retention (Mean) of Omafilcon A and Delefilcon A11.5 percentage of dehyrdationStandard Deviation 5.2
Primary

Moisture Retention (Median) of Omafilcon A and Delefilcon A

Comparison between lens types up to and at 12 hours of wear of moisture retention by measuring relative percentage dehydration (RPD).

Time frame: 12 Hours

Population: Because of the outliers across three participants, the sample size for statistical analysis is reduced to 18 pairs.

ArmMeasureValue (MEDIAN)
Omafilcon AMoisture Retention (Median) of Omafilcon A and Delefilcon A1.98 percentage of dehyrdation
Delefilcon AMoisture Retention (Median) of Omafilcon A and Delefilcon A9.89 percentage of dehyrdation

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026